LRCX vs PTGX · P/E 71, rev $23.23B vs rev $269.8M
Lam Research Corp (LRCX) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the LRCX and PTGX stock pages for the full models.
Not investment advice.